003000.KO Bukwang Pharm

Healthcare Pharmaceuticals Korea Stock Exchange
3,855 KRW
Close of Nov 5, 2026
3,519 9,890
Market cap
KRW 380B
P/E
43.2x
P/B
1.13x
ROE
1.5%
Dividend yield
1.30%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 003000.KO undervalued?

Graham number
Price3,855
Graham value2,614
Premium47.5%

003000.KO trades 47.5% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Bukwang Pharm fundamental analysis

No fundamental analysis for Bukwang Pharm yet.

Bukwang Pharm stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Bukwang Pharm

Bukwang Pharmaceutical Co., Ltd. develops, produces, and sells pharmaceutical products in South Korea and internationally. It offers its products in oral solid dosage forms, injections, oral solutions, external solutions, and ointments. The company also provides ethical drugs, including drugs for treating diabetic peripheral neuropathy, hypothyroidism, toxic liver disease, chronic hepatitis, liver cirrhosis, and iron-deficiency anemia; over-the-counter drugs, such as fever a…

Full company profile